Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

183.24
Data as of Jan 30
 -4.81 / -2.56%
Today’s Change
136.37
Today|||52-Week Range
203.30
-0.97%
Year-to-Date
Qiagen (QGEN) Disappoints with Q4 Earnings, Revenue Miss - Analyst Blog
Jan 30 / Zacks.com
Sanofi's Cerdelga Cleared in the EU for Gaucher Disease - Analyst Blog
Jan 23 / Zacks.com
Alexion Pharmaceuticals (ALXN) Jumps: Stock Rises 5.8% - Tale of the Tape
Jan 30 / Zacks.com
BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog
Jan 22 / Zacks.com
Incyte's Phase III RESPONSE Data on Jakafi Published - Analyst Blog
Jan 29 / Zacks.com
Illumina Launches MiSeq FGx for Forensic DNA Analysis - Analyst Blog
Jan 22 / Zacks.com
Alexion Misses on Q4 Earnings, 2015 Outlook Disappoints - Analyst Blog
Jan 29 / Zacks.com
Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog
Jan 22 / Zacks.com
Salix Financial Results Need Correcting: Audit Committee - Analyst Blog
Jan 29 / Zacks.com
Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog
Jan 22 / Zacks.com
Celgene Q4 Earnings & Revenues In Line, Revlimid Sales Up - Analyst Blog
Jan 29 / Zacks.com
Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog
Jan 22 / Zacks.com
Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog
Jan 29 / Zacks.com
Merrimack Reveals Additional Data from Oncology Candidate - Analyst Blog
Jan 22 / Zacks.com
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Jan 29 / Zacks.com
Celgene to Use Zymeworks' Azymetric Platform for New Drugs - Analyst Blog
Jan 22 / Zacks.com
Early Morning Activity Shows Alexion Pharmaceuticals (ALXN) Down
Jan 29 / TheStreet.com
Kite Pharma (KITE) in Focus: Stock Tumbles 9.2% - Tale of the Tape
Jan 22 / Zacks.com
Pluristem Therapeutics (PSTI) in Focus: Stock Surges 20.4% - Tale of the Tape
Jan 29 / Zacks.com
Keryx Biopharmaceuticals (KERX) in Focus: Stock Falls by 6.8% - Tale of the Tape
Jan 22 / Zacks.com
Alexion (ALXN) Misses on Q4 Earnings, Appoints New CEO - Tale of the Tape
Jan 29 / Zacks.com
Alnylam to Raise $450 Million Through Issuance of Shares - Analyst Blog
Jan 21 / Zacks.com
Frontrunning: January 29
Jan 29 / Investing Channel
State of the Union Address Investing Idea: Precision Medicine
Jan 21 / MotleyFool.com
Earnings Scheduled For January 29, 2015
Jan 29 / Benzinga
Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog
Jan 21 / Zacks.com
Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog
Jan 28 / Zacks.com
Applied Genetic Technologies (AGTC) in Focus: Stock Rises 6.6% - Tale of the Tape
Jan 21 / Zacks.com
Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals - Analyst Blog
Jan 27 / Zacks.com
AMAG Pharmaceuticals (AMAG) in Focus: Stock Rises 5.8% - Tale of the Tape
Jan 21 / Zacks.com
The Medicines Co. Gets CHMP Recommendation for 3 Drugs - Analyst Blog
Jan 27 / Zacks.com
Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst Blog
Jan 20 / Zacks.com
Will Alexion's (ALXN) Soliris Drive Q4 Earnings Beat? - Analyst Blog
Jan 27 / Zacks.com
Celgene Up as Otezla Gains EU Approval for Two Indications - Analyst Blog
Jan 19 / Zacks.com
5 Big Biotech Earnings Releases To Watch This Week
Jan 26 / Benzinga
Alkermes plc (ALKS) in Focus: Stock Moves 6.6% Higher - Tale of the Tape
Jan 19 / Zacks.com
Minerva Neurosciences Gains on Positive Data on MIN-202 - Analyst Blog
Jan 23 / Zacks.com
BioDelivery Sciences International (BDSI) in Focus: Stock Up 5% - Tale of the Tape
Jan 19 / Zacks.com

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.